Albemarle Stock Forecast, Price & News

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last twelve months. There are currently 4 sell ratings, 7 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Albemarle stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View analyst ratings for Albemarle or view top-rated stocks.

Wall Street analysts have given Albemarle a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Albemarle wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Albemarle saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,190,000 shares, a decrease of 20.9% from the March 15th total of 2,770,000 shares. Based on an average daily volume of 1,770,000 shares, the short-interest ratio is presently 1.2 days.
View Albemarle's Short Interest.

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Albemarle.

Albemarle will be holding an earnings conference call on Wednesday, May 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Albemarle Co. (NYSE:ALB) announced its earnings results on Tuesday, February, 16th. The specialty chemicals company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.10 by $0.07. The specialty chemicals company had revenue of $879.15 million for the quarter, compared to analysts' expectations of $876.15 million. Albemarle had a trailing twelve-month return on equity of 11.96% and a net margin of 11.77%. During the same period in the previous year, the company posted $1.73 EPS.
View Albemarle's earnings history.

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ALB shares have increased by 122.3% and is now trading at $155.80.
View which stocks have been most impacted by COVID-19.

Albemarle declared a quarterly dividend on Thursday, February 25th. Stockholders of record on Friday, March 12th will be given a dividend of $0.39 per share on Thursday, April 1st. This represents a $1.56 annualized dividend and a dividend yield of 1.00%. The ex-dividend date of this dividend is Thursday, March 11th. This is a positive change from Albemarle's previous quarterly dividend of $0.39.
View Albemarle's dividend history.

Albemarle pays an annual dividend of $1.56 per share and currently has a dividend yield of 1.02%. Albemarle has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Albemarle is 25.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Albemarle will have a dividend payout ratio of 39.00% next year. This indicates that Albemarle will be able to sustain or increase its dividend.
View Albemarle's dividend history.

Albemarle issued an update on its FY 2021 After-Hours earnings guidance on Wednesday, February, 17th. The company provided earnings per share guidance of 3.25-3.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.08. The company issued revenue guidance of $3.2-3.3 billion, compared to the consensus revenue estimate of $3.19 billion.

21 equities research analysts have issued 12-month target prices for Albemarle's shares. Their forecasts range from $50.00 to $200.00. On average, they expect Albemarle's stock price to reach $129.55 in the next year. This suggests that the stock has a possible downside of 16.9%.
View analysts' price targets for Albemarle or view top-rated stocks among Wall Street analysts.

63 employees have rated Albemarle CEO Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among Albemarle's employees.

Some companies that are related to Albemarle include The Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Valaris (VAL), Celanese (CE), RPM International (RPM), Ashland Global (ASH), Quaker Chemical (KWR), W. R. Grace & Co. (GRA), NewMarket (NEU), Balchem (BCPC), H.B. Fuller (FUL), Sensient Technologies (SXT), Stepan (SCL) and Minerals Technologies (MTX).
View all of ALB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by many different retail and institutional investors. Top institutional investors include Grandfield & Dodd LLC (0.12%), Scout Investments Inc. (0.12%), New York State Teachers Retirement System (0.12%), OLD National Bancorp IN (0.07%), Chevy Chase Trust Holdings Inc. (0.07%) and Retirement Systems of Alabama (0.04%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., John G Ullman & Associates Inc., OLD National Bancorp IN, New York State Teachers Retirement System, Private Advisor Group LLC, Grandfield & Dodd LLC, Crossmark Global Holdings Inc., and Veracity Capital LLC. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford, and Scott Tozier.
View insider buying and selling activity for Albemarle or view top insider-selling stocks.

ALB stock was purchased by a variety of institutional investors in the last quarter, including Handelsinvest Investeringsforvaltning, Ingalls & Snyder LLC, NuWave Investment Management LLC, Asset Advisors Investment Management LLC, Hanlon Investment Management Inc., DnB Asset Management AS, BOKF NA, and Leavell Investment Management Inc.. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle or or view top insider-buying stocks.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALB stock can currently be purchased for approximately $155.80.

Albemarle has a market capitalization of $18.18 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis.

Albemarle employs 5,900 workers across the globe.

The following companies are subsidiares of Albemarle: ACI Cyprus L.L.C., Albemarle (Thailand) Co. Ltd., Albemarle Argentina SRL, Albemarle Brazil Holdings LTDA., Albemarle Care Fund, Albemarle Catalysts Company B.V., Albemarle Chemical Canada Ltd., Albemarle Chemicals (Shanghai) Company Limited, Albemarle Chemicals Ltd., Albemarle Chemicals Private Limited, Albemarle Chemicals S.A.S., Albemarle Chemicals South Africa (PTY) Ltd., Albemarle Delaware Holdings 1 LLC, Albemarle Delaware Holdings 2 LLC, Albemarle Dutch Holdings 2 B.V., Albemarle Dutch Holdings B.V., Albemarle Europe Sprl, Albemarle Finance Company B.V., Albemarle Foundation, Albemarle Germany Gmbh, Albemarle Hilfe GmbH Unterstutzungskasse, Albemarle Holdings Company Limited, Albemarle Holdings Limited, Albemarle Hungary Ltd., Albemarle Italy S.R.L., Albemarle Japan Corporation, Albemarle Japan Holdings B.V., Albemarle Knight Lux 1 Holdings Corporation, Albemarle Korea Corporation, Albemarle Limitada, Albemarle Lithium Holding Corporation, Albemarle Lithium Holding GmbH, Albemarle Lithium Pty Ltd, Albemarle Malaysia Sdn Bhd, Albemarle Management (Shanghai) Co. Ltd., Albemarle Middle East Corporation FZE, Albemarle Netherlands B.V., Albemarle New Holding GmbH, Albemarle Overseas Employment Corporation, Albemarle Quimica LTDA, Albemarle Saudi Trading Company, Albemarle Singapore PTE LTD, Albemarle Spain S.L., Albemarle Taiwan Limited, Albemarle U.S. Inc., Albemarle Vietnam Limited Liability Company, Albemarle Wodgina Pty Ltd, Albemarle de Venezuela C.A., Dynamit Nobel GmbH, Dynamit Nobel Unterstützungsfonds GmbH, Excalibur II Realty Company, Excalibur Realty Company, Foote Chile Holding Company, Foote Minera e Inversiones Ltda., Jiangxi Albemarle Lithium Co. Ltd., Jordan Bromine Company Limited, Knight Lux 1 S.à r.l., Knight Lux 2 S.à r.l., MARBL Lithium Operations Pty Ltd, Metalon Environmental Management & Solutions GmbH, PT Albemarle Chemicals Indonesia, RSG Immobilien GmbH, RT Lithium Limited, Rockwood Holdings, Rockwood Holdings Inc., Rockwood Lithium India Pvt. Ltd., Rockwood Lithium Japan K.K., Rockwood Lithium Korea LLC, Rockwood Lithium Shanghai Co. Ltd., Rockwood Lithium Taiwan Co. Ltd., Rockwood Specialties GmbH, Rockwood Specialties Group LLC, Rockwood Specialties LLC, Rockwood Specialties Limited, Sales de Magnesio Limitada, Shandong Sinobrom Albemarle Bromine Chemicals Company Limited, and Sichuan Guorun New Material Co. Ltd..

Albemarle was founded in 1994.

The official website for Albemarle is www.albemarle.com.

Albemarle is headquartered at 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]